{
  "DOI": "10.1007/s10689-013-9624-0",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-013-9624-0",
  "alternative-id": [
    "9624"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pal",
      "given": "Tuya",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Vadaparampil",
      "given": "Susan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kim",
      "given": "Jongphil",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xu",
      "given": "Yan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Friedman",
      "given": "Sue",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Narod",
      "given": "Steven A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Metcalfe",
      "given": "Kelly",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        3,
        15
      ]
    ],
    "date-time": "2013-03-15T15:38:54Z",
    "timestamp": 1363361934000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:10Z",
    "timestamp": 1559252770000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        4,
        5
      ]
    ],
    "date-time": "2022-04-05T00:59:23Z",
    "timestamp": 1649120363832
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2013,
        3,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2013,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            3,
            16
          ]
        ],
        "date-time": "2013-03-16T00:00:00Z",
        "timestamp": 1363392000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9624-0.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-013-9624-0/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9624-0",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "615-619",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2013,
        3,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        3,
        16
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1093/jnci/91.15.1310",
      "author": "M Chiaro Del",
      "doi-asserted-by": "crossref",
      "first-page": "1310",
      "journal-title": "J Natl Cancer Inst",
      "key": "9624_CR1",
      "unstructured": "Del Chiaro M et al (1999) BCLC. Cancer risks in BRCA2 mutation carriers. The breast cancer linkage consortium. J Natl Cancer Inst 91:1310–1316",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1136/jmg.2004.028829",
      "author": "CJ Asperen van",
      "doi-asserted-by": "crossref",
      "first-page": "711",
      "journal-title": "J Med Genet",
      "key": "9624_CR2",
      "unstructured": "van Asperen CJ et al (2005) Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 42:711–719",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/djj465",
      "author": "HA Risch",
      "doi-asserted-by": "crossref",
      "first-page": "1694",
      "journal-title": "J Natl Cancer Inst",
      "key": "9624_CR3",
      "unstructured": "Risch HA et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario Canada. J Natl Cancer Inst 98:1694–1706",
      "volume": "98",
      "year": "2006"
    },
    {
      "DOI": "10.1086/318787",
      "author": "HA Risch",
      "doi-asserted-by": "crossref",
      "first-page": "700",
      "journal-title": "Am J Hum Genet",
      "key": "9624_CR4",
      "unstructured": "Risch HA et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700–710",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1086/342506",
      "author": "A Liede",
      "doi-asserted-by": "crossref",
      "first-page": "595",
      "journal-title": "Am J Hum Genet",
      "key": "9624_CR5",
      "unstructured": "Liede A et al (2002) Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 71:595–606",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1086/302853",
      "author": "R Moslehi",
      "doi-asserted-by": "crossref",
      "first-page": "1259",
      "journal-title": "Am J Hum Genet",
      "key": "9624_CR6",
      "unstructured": "Moslehi R et al (2000) BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66:1259–1272",
      "volume": "66",
      "year": "2000"
    },
    {
      "DOI": "10.1038/sj.bjc.6604453",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "371",
      "journal-title": "Br J Cancer",
      "key": "9624_CR7",
      "unstructured": "Narod SA et al (2008) Rapid progression of prostate cancer in men with a BRCA2 mutation. Br J Cancer 99:371–374",
      "volume": "99",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-1822",
      "author": "I Agalliu",
      "doi-asserted-by": "crossref",
      "first-page": "1112",
      "journal-title": "Clin Cancer Res",
      "key": "9624_CR8",
      "unstructured": "Agalliu I, Gern R, Leanza S, Burk RD (2009) Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res 15:1112–1120",
      "volume": "15",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.bjc.6604132",
      "author": "A Mitra",
      "doi-asserted-by": "crossref",
      "first-page": "502",
      "journal-title": "Br J Cancer",
      "key": "9624_CR9",
      "unstructured": "Mitra A et al (2008) Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer 98:502–507",
      "volume": "98",
      "year": "2008"
    },
    {
      "DOI": "10.1093/jnci/djm005",
      "author": "L Tryggvadottir",
      "doi-asserted-by": "crossref",
      "first-page": "929",
      "journal-title": "J Natl Cancer Inst",
      "key": "9624_CR10",
      "unstructured": "Tryggvadottir L et al (2007) Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 99:929–935",
      "volume": "99",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.bjc.6605822",
      "author": "SM Edwards",
      "doi-asserted-by": "crossref",
      "first-page": "918",
      "journal-title": "Br J Cancer",
      "key": "9624_CR11",
      "unstructured": "Edwards SM et al (2010) Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. Br J Cancer 103:918–924",
      "volume": "103",
      "year": "2010"
    },
    {
      "DOI": "10.1158/1940-6207.CAPR-10-0397",
      "author": "H Thorne",
      "doi-asserted-by": "crossref",
      "first-page": "1002",
      "journal-title": "Cancer Prev Res (Phila)",
      "key": "9624_CR12",
      "unstructured": "Thorne H et al (2011) Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families. Cancer Prev Res (Phila) 4:1002–1010",
      "volume": "4",
      "year": "2011"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-4100",
      "author": "M Fiorentino",
      "doi-asserted-by": "crossref",
      "first-page": "3136",
      "journal-title": "Cancer Res",
      "key": "9624_CR13",
      "unstructured": "Fiorentino M et al (2010) Immunohistochemical expression of BRCA1 and lethal prostate cancer. Cancer Res 70:3136–3139",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-2871",
      "author": "DJ Gallagher",
      "doi-asserted-by": "crossref",
      "first-page": "2115",
      "issue": "7",
      "journal-title": "Clin Cancer Res",
      "key": "9624_CR14",
      "unstructured": "Gallagher DJ et al (2010) Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res 16(7):2115–2121",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1464-410X.2010.09648.x",
      "author": "AV Mitra",
      "doi-asserted-by": "crossref",
      "first-page": "28",
      "issue": "1",
      "journal-title": "BJU Int",
      "key": "9624_CR15",
      "unstructured": "Mitra AV et al (2008) Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int 107(1):28–39",
      "volume": "107",
      "year": "2008"
    },
    {
      "DOI": "10.1038/gim.0b013e3182310ba0",
      "author": "DC Landy",
      "doi-asserted-by": "crossref",
      "first-page": "223",
      "journal-title": "Genet Med",
      "key": "9624_CR16",
      "unstructured": "Landy DC et al (2012) How disease advocacy organizations participate in clinical research: a survey of genetic organizations. Genet Med 14:223–228",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10689-011-9425-2",
      "author": "KD Graves",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "issue": "2",
      "journal-title": "Fam Cancer",
      "key": "9624_CR17",
      "unstructured": "Graves KD et al (2011) BRCA1/2 genetic testing uptake and psychosocial outcomes in men. Fam Cancer 10(2):213–223",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1089/gte.2007.0037",
      "author": "E Finlay",
      "doi-asserted-by": "crossref",
      "first-page": "81",
      "journal-title": "Genet Test",
      "key": "9624_CR18",
      "unstructured": "Finlay E et al (2008) Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test 12:81–91",
      "volume": "12",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1399-0004.2008.01146.x",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "124",
      "journal-title": "Clin Genet",
      "key": "9624_CR19",
      "unstructured": "Evans DG, Binchy A, Shenton A, Hopwood P, Craufurd D (2009) Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clin Genet 75:124–132",
      "volume": "75",
      "year": "2009"
    },
    {
      "DOI": "10.1111/1467-8519.00234",
      "author": "L d’Agincourt-Canning",
      "doi-asserted-by": "crossref",
      "first-page": "231",
      "journal-title": "Bioethics",
      "key": "9624_CR20",
      "unstructured": "d’Agincourt-Canning L (2001) Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 15:231–247",
      "volume": "15",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.critrevonc.2006.03.001",
      "author": "L d’Agincourt-Canning",
      "doi-asserted-by": "crossref",
      "first-page": "114",
      "journal-title": "Crit Rev Oncol Hematol",
      "key": "9624_CR21",
      "unstructured": "d’Agincourt-Canning L, Baird P (2006) Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations. Crit Rev Oncol Hematol 58:114–123",
      "volume": "58",
      "year": "2006"
    },
    {
      "DOI": "10.1002/ajmg.c.10003",
      "author": "J Wagner Costalas",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "journal-title": "Am J Med Genet C Semin Med Genet",
      "key": "9624_CR22",
      "unstructured": "Wagner Costalas J et al (2003) Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. Am J Med Genet C Semin Med Genet 119C:11–18",
      "volume": "119C",
      "year": "2003"
    },
    {
      "DOI": "10.1111/j.1399-0004.2005.00443.x",
      "author": "N Hallowell",
      "doi-asserted-by": "crossref",
      "first-page": "492",
      "journal-title": "Clin Genet",
      "key": "9624_CR23",
      "unstructured": "Hallowell N et al (2005) Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet 67:492–502",
      "volume": "67",
      "year": "2005"
    },
    {
      "DOI": "10.1136/jmg.35.9.739",
      "author": "MF McAllister",
      "doi-asserted-by": "crossref",
      "first-page": "739",
      "journal-title": "J Med Genet",
      "key": "9624_CR24",
      "unstructured": "McAllister MF, Evans DG, Ormiston W, Daly P (1998) Men in breast cancer families: a preliminary qualitative study of awareness and experience. J Med Genet 35:739–744",
      "volume": "35",
      "year": "1998"
    },
    {
      "DOI": "10.1034/j.1399-0004.2003.00142.x",
      "author": "K Forrest",
      "doi-asserted-by": "crossref",
      "first-page": "317",
      "journal-title": "Clin Genet",
      "key": "9624_CR25",
      "unstructured": "Forrest K et al (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64:317–326",
      "volume": "64",
      "year": "2003"
    },
    {
      "DOI": "10.1093/annonc/mdg164",
      "author": "PA Daly",
      "doi-asserted-by": "crossref",
      "first-page": "549",
      "journal-title": "Ann Oncol",
      "key": "9624_CR26",
      "unstructured": "Daly PA et al (2003) Predictive testing for BRCA1 and 2 mutations: a male contribution. Ann Oncol 14:549–553",
      "volume": "14",
      "year": "2003"
    }
  ],
  "reference-count": 26,
  "references-count": 26,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-013-9624-0"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers"
  ],
  "type": "journal-article",
  "volume": "12"
}